UK's Sovereign AI Gambit: Funding Drug Discovery, Fueling a Nation
The UK's £500m investment in an AI drug discovery startup signals a bold sovereign play. Will it spark a biotech boom or just burn cash?
31d ago
OpenAI's Australian Blueprint: A Smokescreen or a Strategic Stride in AI Safety?
OpenAI's "Australian Youth Safety Blueprint" signals a critical shift in AI governance. But is it genuine protection or a PR play in the competitive 2026 AI lan
31d ago
Google's Search Race Prep: A Glimpse into AI-Powered Personalization's Future
Google's latest blog post hints at AI-driven personalization transforming search from mere information retrieval to proactive, tailored assistance for users.
39d ago
The Double-Edged Sword of AI Refusal: Why Nuance is Non-Negotiable
AI models' refusal to answer is evolving, but the core problem of over-refusal persists. This piece dissects why models like gpt-6-astra struggle with nuance.
42d ago
The Million-Dollar Math Problem: AI's Latest Controversy and the Future of Proof
OpenAI's latest mathematical "milestone" is mired in controversy. We dig into what this means for AI's role in fundamental science and its impact on trust.
43d ago
OpenAI's Rogue Agents: The Unseen Threat Lurking in Your AI Stack
OpenAI's "rogue agents" aren't just a quirky news item; they're a chilling preview of autonomous AI risks for developers and businesses in 2026.
44d ago
The Alien Minds Among Us: OpenAI's Warning and the Looming Alignment Crisis
OpenAI's Jakub Pachocki warns of increasingly capable AI and the alignment challenge. DruxAI investigates the implications for safety, governance, and model dev
45d ago